NASDAQ:BCDA

BioCardia News Headlines

$3.45
+0.19 (+5.83 %)
(As of 05/7/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.23
$3.48
50-Day Range
$3.26
$4.61
52-Week Range
$1.91
$8.60
Volume65,697 shs
Average Volume253,755 shs
Market Capitalization$57.94 million
P/E RatioN/A
Dividend YieldN/A
Beta1.98

Headlines

BioCardia (NASDAQ BCDA) News Headlines Today

SourceHeadline
BioCardia Signs Agreement with Leading Japanese Biotechnology Company for Catheter Biotherapeutic Delivery Product Candidates - GlobeNewswireBioCardia Signs Agreement with Leading Japanese Biotechnology Company for Catheter Biotherapeutic Delivery Product Candidates - GlobeNewswire
globenewswire.com - April 26 at 2:08 PM
BioCardia Signs Agreement with Leading Japanese Biotechnology Company for Catheter Biotherapeutic Delivery Product Candidates - Yahoo FinanceBioCardia Signs Agreement with Leading Japanese Biotechnology Company for Catheter Biotherapeutic Delivery Product Candidates - Yahoo Finance
finance.yahoo.com - April 26 at 8:23 AM
BioCardia Signs Agreement with Leading Japanese Biotechnology Company for Catheter Biotherapeutic Delivery Product CandidatesBioCardia Signs Agreement with Leading Japanese Biotechnology Company for Catheter Biotherapeutic Delivery Product Candidates
finance.yahoo.com - April 26 at 8:23 AM
BioCardia (NASDAQ:BCDA) Given Neutral Rating at Dawson JamesBioCardia (NASDAQ:BCDA) Given Neutral Rating at Dawson James
americanbankingnews.com - April 22 at 9:36 AM
BioCardia (NASDAQ:BCDA) Downgraded by Dawson JamesBioCardia (NASDAQ:BCDA) Downgraded by Dawson James
americanbankingnews.com - April 17 at 2:58 PM
BioCardia, Inc. (NASDAQ:BCDA) Sees Significant Increase in Short InterestBioCardia, Inc. (NASDAQ:BCDA) Sees Significant Increase in Short Interest
americanbankingnews.com - April 17 at 1:00 AM
Should You Take Comfort From Insider Transactions At BioCardia, Inc. (NASDAQ:BCDA)? - NasdaqShould You Take Comfort From Insider Transactions At BioCardia, Inc. (NASDAQ:BCDA)? - Nasdaq
nasdaq.com - April 8 at 2:13 PM
Have Insiders Been Buying BioCardia, Inc. (NASDAQ:BCDA) Shares? - Yahoo FinanceHave Insiders Been Buying BioCardia, Inc. (NASDAQ:BCDA) Shares? - Yahoo Finance
finance.yahoo.com - April 1 at 10:13 AM
Have Insiders Been Buying BioCardia, Inc. (NASDAQ:BCDA) Shares?Have Insiders Been Buying BioCardia, Inc. (NASDAQ:BCDA) Shares?
finance.yahoo.com - April 1 at 7:19 AM
BioCardia Reports 2020 Financial Results and Recent Business Highlights - GlobeNewswireBioCardia Reports 2020 Financial Results and Recent Business Highlights - GlobeNewswire
globenewswire.com - April 1 at 5:13 AM
Tencent To Buy Back $1B In Stock; Shares Gain Pre-Market - NasdaqTencent To Buy Back $1B In Stock; Shares Gain Pre-Market - Nasdaq
nasdaq.com - March 31 at 8:39 AM
4 Stocks Poised to Gain From Uptick in Campus Networking Spend - Nasdaq4 Stocks Poised to Gain From Uptick in Campus Networking Spend - Nasdaq
nasdaq.com - March 30 at 10:38 PM
Deutsche (DB) Might File Lawsuit Against Two Ex-Madoff Funds - NasdaqDeutsche (DB) Might File Lawsuit Against Two Ex-Madoff Funds - Nasdaq
nasdaq.com - March 30 at 12:50 PM
BlackBerry (BB) QNX Software Boosts Scanias Heavy Vehicles - NasdaqBlackBerry (BB) QNX Software Boosts Scania's Heavy Vehicles - Nasdaq
nasdaq.com - March 30 at 12:37 PM
Viasat (VSAT) Arm Sets Up Facility in UK to Boost Cybersecurity - NasdaqViasat (VSAT) Arm Sets Up Facility in UK to Boost Cybersecurity - Nasdaq
nasdaq.com - March 30 at 12:37 PM
Form 10-K BioCardia, Inc. For: Dec 31 - StreetInsider.comForm 10-K BioCardia, Inc. For: Dec 31 - StreetInsider.com
streetinsider.com - March 30 at 12:37 PM
BioCardia, Inc. (BCDA) Reports Q4 Loss, Misses Revenue Estimates - Yahoo FinanceBioCardia, Inc. (BCDA) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
finance.yahoo.com - March 30 at 12:37 PM
BioCardia Reports 2020 Financial Results and Recent Business Highlights - Yahoo FinanceBioCardia Reports 2020 Financial Results and Recent Business Highlights - Yahoo Finance
finance.yahoo.com - March 30 at 12:37 PM
BioCardia, Inc. (BCDA) Reports Q4 Loss, Misses Revenue EstimatesBioCardia, Inc. (BCDA) Reports Q4 Loss, Misses Revenue Estimates
finance.yahoo.com - March 30 at 12:36 PM
BioCardia Reports 2020 Financial Results and Recent Business HighlightsBioCardia Reports 2020 Financial Results and Recent Business Highlights
finance.yahoo.com - March 30 at 9:16 AM
BioCardia Is Super Cheap With Multiple Shots On Goal - Seeking AlphaBioCardia Is Super Cheap With Multiple Shots On Goal - Seeking Alpha
seekingalpha.com - March 25 at 2:07 PM
BioCardia to Present at Maxim Group’s Inaugural Emerging Growth Virtual Conference - Yahoo FinanceBioCardia to Present at Maxim Group’s Inaugural Emerging Growth Virtual Conference - Yahoo Finance
finance.yahoo.com - March 15 at 8:12 PM
BioCardia to Present at Maxim Groups Inaugural Emerging Growth Virtual Conference - GlobeNewswireBioCardia to Present at Maxim Group's Inaugural Emerging Growth Virtual Conference - GlobeNewswire
globenewswire.com - March 15 at 8:45 AM
BioCardia to Present at Maxim Group’s Inaugural Emerging Growth Virtual ConferenceBioCardia to Present at Maxim Group’s Inaugural Emerging Growth Virtual Conference
finance.yahoo.com - March 15 at 8:45 AM
BioCardia inks agreement with Japanese pharma companyBioCardia inks agreement with Japanese pharma company
seekingalpha.com - February 24 at 1:31 PM
BioCardia (BCDA) Signs Agreement With Leading Japanese Pharmaceutical Company for Catheter Biotherapeutic Delivery Product Candidates - StreetInsider.comBioCardia (BCDA) Signs Agreement With Leading Japanese Pharmaceutical Company for Catheter Biotherapeutic Delivery Product Candidates - StreetInsider.com
streetinsider.com - February 23 at 7:06 PM
BioCardia Signs Agreement With Leading Japanese Pharmaceutical Company for Catheter Biotherapeutic Delivery Product Candidates - Yahoo FinanceBioCardia Signs Agreement With Leading Japanese Pharmaceutical Company for Catheter Biotherapeutic Delivery Product Candidates - Yahoo Finance
finance.yahoo.com - February 23 at 9:40 AM
BioCardia Signs Agreement With Leading Japanese Pharmaceutical Company for Catheter Biotherapeutic Delivery Product CandidatesBioCardia Signs Agreement With Leading Japanese Pharmaceutical Company for Catheter Biotherapeutic Delivery Product Candidates
finance.yahoo.com - February 23 at 9:40 AM
BioCardia Announces Clinical Leadership Changes - Yahoo Finance AustraliaBioCardia Announces Clinical Leadership Changes - Yahoo Finance Australia
finance.yahoo.com - February 17 at 1:00 PM
BioCardia (BCDA) Update on Cell Therapy Product Development and 2021 Milestones - StreetInsider.comBioCardia (BCDA) Update on Cell Therapy Product Development and 2021 Milestones - StreetInsider.com
streetinsider.com - February 2 at 2:10 PM
BioCardia Update on Cell Therapy Product Development and 2021 Milestones - GlobeNewswireBioCardia Update on Cell Therapy Product Development and 2021 Milestones - GlobeNewswire
globenewswire.com - February 2 at 9:09 AM
BioCardia Update on Cell Therapy Product Development and 2021 MilestonesBioCardia Update on Cell Therapy Product Development and 2021 Milestones
finance.yahoo.com - February 2 at 9:09 AM
Accomplished Biotech Executive Krisztina Zsebo, Ph.D. Joins BioCardias Board of Directors - GlobeNewswireAccomplished Biotech Executive Krisztina Zsebo, Ph.D. Joins BioCardia's Board of Directors - GlobeNewswire
globenewswire.com - January 11 at 9:40 AM
Accomplished Biotech Executive Krisztina Zsebo, Ph.D. Joins BioCardia’s Board of DirectorsAccomplished Biotech Executive Krisztina Zsebo, Ph.D. Joins BioCardia’s Board of Directors
finance.yahoo.com - January 11 at 9:40 AM
Why BioCardias Stock is Up During Todays Session - BenzingaWhy BioCardia's Stock is Up During Today's Session - Benzinga
benzinga.com - December 30 at 7:36 PM
Why BioCardias Stock is Up During Todays SessionWhy BioCardia's Stock is Up During Today's Session
msn.com - December 30 at 1:55 PM
BioCardia Issued New U.S. Patent for Technology that Enhances Control for Cardiac Therapies - GlobeNewswireBioCardia Issued New U.S. Patent for Technology that Enhances Control for Cardiac Therapies - GlobeNewswire
globenewswire.com - December 30 at 9:35 AM
BioCardia, Inc. (6JU.F)BioCardia, Inc. (6JU.F)
ca.finance.yahoo.com - December 21 at 7:36 PM
BioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Heart Failure Study as Designed - Yahoo FinanceBioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Heart Failure Study as Designed - Yahoo Finance
finance.yahoo.com - December 19 at 4:56 AM
Why Is It Moving? Looking Into Why BioCardias Stock is Trading Lower Today - BenzingaWhy Is It Moving? Looking Into Why BioCardia's Stock is Trading Lower Today - Benzinga
benzinga.com - December 17 at 2:53 PM
BioCardia (BCDA) Reports Positive DSMB Review & Recommendation to Continue Phase III Pivotal CardiAMP Heart Failure Study as Designed - StreetInsider.comBioCardia (BCDA) Reports Positive DSMB Review & Recommendation to Continue Phase III Pivotal CardiAMP Heart Failure Study as Designed - StreetInsider.com
streetinsider.com - December 17 at 2:53 PM
Why Is It Moving? Looking Into Why BioCardias Stock is Trading Lower TodayWhy Is It Moving? Looking Into Why BioCardia's Stock is Trading Lower Today
msn.com - December 17 at 1:56 PM
BioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Heart Failure Study as Designed - GlobeNewswireBioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Heart Failure Study as Designed - GlobeNewswire
globenewswire.com - December 17 at 9:52 AM
BioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Heart Failure Study as DesignedBioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Heart Failure Study as Designed
finance.yahoo.com - December 17 at 8:55 AM
BUZZ-U.S. STOCKS ON THE MOVE-BioCardia, Tyson Foods, Moderna - NasdaqBUZZ-U.S. STOCKS ON THE MOVE-BioCardia, Tyson Foods, Moderna - Nasdaq
nasdaq.com - December 16 at 11:05 PM
BUZZ-U.S. STOCKS ON THE MOVE-Arvinas, BioCardia, Hexindai - NasdaqBUZZ-U.S. STOCKS ON THE MOVE-Arvinas, BioCardia, Hexindai - Nasdaq
nasdaq.com - December 16 at 1:04 PM
BioCardia, Inc. Announces $10.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Yahoo FinanceBioCardia, Inc. Announces $10.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Yahoo Finance
finance.yahoo.com - December 16 at 1:04 PM
BioCardias stock pulls back after taking advantage of recent doubling with another share sale - MarketWatchBioCardia's stock pulls back after taking advantage of recent doubling with another share sale - MarketWatch
marketwatch.com - December 16 at 1:04 PM
BioCardia, Inc. Announces $10.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesBioCardia, Inc. Announces $10.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
marketwatch.com - December 16 at 12:13 PM
BUZZ-U.S. STOCKS ON THE MOVE-Mirum Pharmaceuticals, BioCardia, United Rentals - NasdaqBUZZ-U.S. STOCKS ON THE MOVE-Mirum Pharmaceuticals, BioCardia, United Rentals - Nasdaq
nasdaq.com - December 15 at 12:00 PM
This page was last updated on 5/9/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.